Illumina Inc

ILMN

NASDAQ. Currency in USD

190.79 -3.02 ( -1.56% )

Real time prices: September 30

Market Cap.
30.01B
Beta (5Y monthly)
1.16
Price/Earnings
50.39
EPS (TTM)
3.84
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
2.78M
1y Target Est.
441.73
Day's Range
183.65
-
194.22
52 Week's Range
173.45
-
428.00

Historical Summary

Performance
EPS growth
Share Buybacks

About Illumina Inc

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.illumina.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
156.30M
Employees
9800
Address
5200 Illumina Way, San Diego, CA, United States, 92122
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Latest news

Illumina (ILMN) Dips More Than Broader Markets: What You Should Know
Illumina (ILMN) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Illumina (ILMN) closed at $190.79, marking a -1.56% move from...
By Zacks Investment Research - 2 days ago

12 Analysts Have This to Say About Illumina
12 Analysts Have This to Say About Illumina

Over the past 3 months, 12 analysts have published their opinion on Illumina (NASDAQ:ILMN) stock....
By Benzinga - 2 days ago

What 12 Analyst Ratings Have To Say About Illumina
What 12 Analyst Ratings Have To Say About Illumina

Analysts have provided the following ratings for Illumina (NASDAQ:ILMN) within the last quarter: Bullish Somewhat...
By Benzinga - 2 days ago

Netflix, Biogen And Other Big Gainers From Wednesday
Netflix, Biogen And Other Big Gainers From Wednesday

U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday....
By Benzinga - 4 days ago

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022

Upgrades According to B of A Securities, the prior rating for Prothena Corp PLC (NASDAQ:PRTA)...
By Benzinga - 4 days ago

Illumina (ILMN) Stock Moves -1.61%: What You Should Know
Illumina (ILMN) Stock Moves -1.61%: What You Should Know

Illumina (ILMN) closed at $190.38 in the latest trading session, marking a -1.61% move from...
By Zacks Investment Research - 1 week ago

Illumina (ILMN) Dips More Than Broader Markets: What You Should Know
Illumina (ILMN) Dips More Than Broader Markets: What You Should Know

Illumina (ILMN) closed the most recent trading day at $199.88, moving -1.03% from the previous...
By Zacks Investment Research - 2 weeks ago

20 value stocks whose growth potential is overlooked by investors
20 value stocks whose growth potential is overlooked by investors

Value stocks have held up better than growth stocks this year, and that trend may...
By MarketWatch - 2 weeks ago